Quantum BioPharma Ltd. announced in its Q3 financial results that its Bitcoin-focused digital asset portfolio generated $572,000 in year-to-date gains.
According to its official Q3 financial report, Quantum BioPharma Ltd. recorded $572,000 in year-to-date gains from its digital asset portfolio, which is primarily composed of Bitcoin. The Canadian biopharmaceutical company’s disclosure underscores its strategic exposure to cryptocurrency investments.